Clinical trials recruiting in Itabashi-ku, Japan
9
Recruiting trials
15
Conditions
Phase breakdown
Phase 2 1Phase 3 6Phase 4 1Not applicable 1
Conditions recruiting in Itabashi-ku, Japan
Recruiting trials in Itabashi-ku, Japan
- A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
- A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
- A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
- Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Non-antithrombotic Versus. Single Antiplatelet Therapy Following Left Atrial Appendage Closure
- Pancreatic Cancer Screening Using the Enzeavour Assay in Japan
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Common questions
How many clinical trials are recruiting in Itabashi-ku, Japan?
9 recruiting trials have at least one study site in Itabashi-ku, Japan.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.